Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : BOS-356
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : BOS-356 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 14, 2019
Lead Product(s) : BOS-356
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : BOS-356
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Nucleus Network
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : GSK3008356 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 19, 2016
Lead Product(s) : BOS-356
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Nucleus Network
Deal Size : Inapplicable
Deal Type : Inapplicable